AI-Driven Molecular Design and Docking of Ferroptosis Inhibitors for Parkinson’s Disease
This study combines AI-driven molecular design with computational docking validation to identify novel ferroptosis inhibitors for Parkinson's disease treatment.
Posted by buchanle on Monday, June 1st, 2026 in May 2026, Drug Discovery, Ferroptosis, Machine learning, Molecular Docking, Parkinson’s disease